As part of its “AIDS Turning Point” series, GlobalPost examines how the United States and its African partners are designing clinical trials at four African sites to test whether a combination of prevention methods and strategies — “notably the vaccine-like preventative effect on transmission when someone starts taking AIDS drugs, as well as the life-long protection afforded to many due to male circumcision” — could “put them on the road to a Holy Grail: the numbers of HIV infections tumbling down.”
“A global study mapping human diseases that come from animals like tuberculosis, AIDS, bird flu or Rift Valley fever has found that just 13 such diseases are responsible for 2.4 billion cases of human illness and 2.2 million deaths a year,” Reuters reports (Kelland, 7/5). “The report, which was conducted by the International Livestock Research Institute (ILRI), the Institute of Zoology (U.K.) and the Hanoi School of Public Health in Vietnam, maps poverty, livestock-keeping and the diseases humans get from animals, and presents a ‘top 20’ list of geographical hotspots,” an ILRI press release states (7/5). The study “found that Ethiopia, Nigeria, and Tanzania, as well as India have the highest zoonotic disease burdens, with widespread illness and death,” Reuters writes.
Isobel Coleman, senior fellow for U.S. foreign policy at the Council on Foreign Relations (CFR) and director of the Civil Society, Markets, and Democracy Initiative, examines the “massive food crisis … brewing in Africa’s Sahel” in this post on CFR’s “Democracy in Development” blog. She writes, “The hunger crisis is most immediately tied to inadequate rainfall, small crop yields, and high food prices, but conflict makes the situation all the more severe,” and goes on to highlight the situations in Mali and Niger. She says ending the “‘buy American’ tied aid policy,” implementing longer-term solutions other than food aid, and providing additional funding for relief efforts would help alleviate the situation in the Sahel (7/4).
In this audio report in PRI’s “The World,” PRI anchor “Aaron Schachter talks to Agnes Odhiambo, a researcher on women’s rights in Africa for New York-based Human Rights Watch, about the terrible toll of teenage pregnancy and childbirth in Africa.” “Teenage pregnancy is an issue of pandemic proportions in Africa,” Odhiambo said, adding, “Teenage pregnancy is really an issue that has serious negative consequences for girls, for the development of communities and for the development of cultures.” She discussed progress toward reducing maternal deaths in various African countries and said that a number of factors contribute to maternal mortality, including a lack of sexual education for young girls, some traditional practices, such as early marriage, and the inadequate provision of health services (7/3).
“Earlier this week the Centre for Research in the Arts, Social Sciences and Humanities (CRASSH) at the University of Cambridge, U.K. hosted a conference called New Approaches to Maternal Mortality in Africa,” Paul Simpson, the associate editor at PLoS Medicine, reports in the PLoS “Speaking of Medicine” blog, writing, “The conference brought together diverse expertise from obstetricians to policymakers and historians with the aim of focusing on both the biological mechanisms from determining birth outcomes, as well as the social and historical context of maternal mortality in Africa.” Simpson posts a video interview with conference organizer Professor Ashley Moffett, who discusses the motivations behind the conference, and a second video “featuring Annette Nakimuli, an obstetrician and gynecologist from Uganda, who discusses her research on preeclampsia and her experiences working in Uganda” (7/4).
NPR’s “All Things Considered” on Tuesday featured an interview of U.S. Global AIDS Coordinator Ambassador Eric Goosby by host Robert Siegel. Goosby discusses PEPFAR’s success at treating people living with HIV/AIDS in other countries, including Haiti, Rwanda, and Botswana, as well as the cost of treatment. Goosby said, “[I]n the time that President Obama’s administration has taken over the helm of PEPFAR, we have gone from 1.7 million people on treatment to close to four million people on treatment. Our ability to identify, enter and retain these individuals in treatment programs is mapped out. We know where we’re going. We know what groups we have to increase our testing and outreach efforts in, and I am confident we will meet all of the World AIDS Day goals with the current budget setting.” A complete transcript and audio of the interview is available online (7/3).
UNICEF and the WHO “are warning of an alarming upsurge in cholera across West Africa’s Sahel region, the area at the southern fringe of the Sahara Desert running from Mauritania to Chad,” VOA News reports (Schlein, 7/10). “So far in 2012, cholera has killed nearly 700 people in West and Central Africa and more than 29,000 cases were reported,” according to a UNICEF press release (7/10). “Both UNICEF and WHO say they are critically short of funds to do what is needed to contain the outbreak,” but “[t]hey say action must be taken now before the number of cholera cases explodes,” VOA writes (7/10). IRIN examines efforts to curb the spread of cholera in Guinea, with the administration of a vaccine, and Sierra Leone (7/10).
“Many of Africa’s anti-malaria drugs are fake or of poor quality, weakening a crucial battle against the world’s deadliest disease, a new investigation has found,” GlobalPost reports, adding, “Many of the drugs — even those approved by the World Health Organization — are Chinese fakes or low-quality variants that failed quality tests, according to two new studies released today” (Conway-Smith, 7/10). “Two studies published in Research and Reports in Tropical Medicine suggested manufacturing problems, rather than counterfeiting, may be to blame for these substandard drugs in low- and middle-income countries around the world,” Agence France-Presse writes (7/10). Writing in a Business Day opinion piece published on Tuesday, “Roger Bate, lead author of the studies and a scholar at the conservative American Enterprise Institute, warned of ‘unthinkable’ public health consequences from drug resistance,” GlobalPost notes.
Cuban Company's Sales Of Larvicides To Fight Malaria-Carrying Mosquitoes In Africa Continue Despite U.N. Concern, Miami Herald Reports
The Cuban state-owned company Labiofam “is increasing sales of its mosquito larvicides to fight malaria in Africa, despite cautions by U.N. experts that such products have limited use and are not the most cost-effective method of attacking the disease,” the Miami Herald reports. The company’s website “says its larvicide Griselesf is used in anti-malaria programs in Ghana, Angola, Gambia, Tanzania, Nigeria, Burkina Faso, Equatorial Guinea, and Zambia,” according to the newspaper.
“A summit designed to kickstart a joint effort by world leaders to address hunger and malnutrition will be held in London on 12 August to coincide with the closing day of the Olympics, the British government has announced,” the Guardian reports. “It’s really important that, while the eyes of the world are on Britain and we are going to put on this fantastic show for the Olympics, we remember people in other parts of the world who, far from being excited about the Olympics, are actually worried about their next meal and whether they are getting enough to eat,” British Prime Minister David Cameron said, adding, “We are going to have other world leaders [involved] â€¦ to challenge the world to tackle the problem of malnutrition, hunger and stunted growth,” according to the newspaper. Cameron first announced the summit following the G8 meeting in May, the newspaper notes (Marchal, 7/27).